“Immune thrombocytopenia is a disorder of the immune system responsible for the drop in the number of platelets in the blood of those who suffer from it. ITP exposes patients to a greater risk of bleeding and causes serious difficulties in everyday life. For people with ITP. it is in fact very easy to develop spontaneous hemorrhages, epistaxis, petechiae and bruises. In the most serious cases the hemorrhages affect very important parts of the body, such as the brain and digestive system, with the need for hospitalization. Fortunately, however, these are episodes rare “. This was stated by Nicola Vianelli, hematologist at the ‘Seragnoli’ Institute of Hematology of the Sant’Orsola-Malpighi Polyclinic in Bologna and president of the Scientific Committee of Aipit Aps Onlus, on the occasion of the presentation of the ‘Itp – Traveling with Werlhof’ initiative , which aims to raise awareness more and more people about immune thrombocytopenia and to make people with ITP savor a newfound sense of freedom.
“For twenty years now – continued Vianelli – medical-scientific progress has developed drugs and therapies capable of returning patients to a quality of life close to normal. After passing from drugs with immunosuppressive activity to receptor agonists of thrombopoietin (Tpo-Ra), two new drugs have now been found, included in the national medical handbook: avatrombopag, a new thrombopoietin receptor agonist, and fostamatinib, which has a completely different mechanism of action from drugs that have been used so far. The introduction of these two drugs will guarantee patients undoubtedly better care and quality of life “.
#Hematologist #Vianelli #drugs #life #ITP #patients